Evidence map›Paper›PMID 37071732›Full record

ArticleScience signaling2023

Oct1 cooperates with the Smad family of transcription factors to promote mesodermal lineage specification.

Jelena Perovanovic, Yifan Wu, Hosiana Abewe, Zuolian Shen, Erik P Hughes, Jason Gertz, Mahesh B Chandrasekharan, Dean Tantin

Open access · greenAbstract read
In one paragraph

Article in Science signaling, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. OCA-B/Pou2af1 is sufficient to promote CD4Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jelena PerovanovicDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.ORCID 0000-0003-2348-2332
Yifan WuDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.ORCID 0000-0001-6345-4219
Hosiana AbeweHuntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.ORCID 0000-0003-3003-1177
Zuolian ShenDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
Erik P HughesDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.ORCID 0000-0001-8672-3928
Jason GertzHuntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.ORCID 0000-0001-7568-6789
Mahesh B ChandrasekharanHuntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.ORCID 0000-0002-9956-8354
Dean TantinDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.ORCID 0000-0003-1354-8385
University of Utah · US

Funding

Structure, function and regulation of the H2B ubiquitin-conjugating complexR01GM127783 · NIGMS · UNIVERSITY OF UTAH · PI CHANDRASEKHARAN, MAHESH B · 2018 to 2022
$1.7M
Developmental gene poising by Oct transcription factorsR01GM122778 · NIGMS · UNIVERSITY OF UTAH · PI TANTIN, DEAN · 2018 to 2021
$1.2M
The Neuroimmunology Training Program at the University of UtahT32NS115664 · NINDS · UNIVERSITY OF UTAH · PI O'CONNELL, RYAN M, WILCOX, KAREN S · 2020 to 2024
$988k
NIGMS NIH HHS R01 GM122778NIGMS NIH HHS R01 GM127783NINDS NIH HHS T32 NS115664
6 · The paper itself

Abstract

The transition between pluripotent and tissue-specific states is a key aspect of development. Understanding the pathways driving these transitions will facilitate the engineering of properly differentiated cells for experimental and therapeutic uses. Here, we showed that during mesoderm differentiation, the transcription factor Oct1 activated developmental lineage-appropriate genes that were silent in pluripotent cells. Using mouse embryonic stem cells (ESCs) with an inducible knockout of Oct1, we showed that Oct1 deficiency resulted in poor induction of mesoderm-specific genes, leading to impaired mesodermal and terminal muscle differentiation. Oct1-deficient cells exhibited poor temporal coordination of the induction of lineage-specific genes and showed inappropriate developmental lineage branching, resulting in poorly differentiated cell states retaining epithelial characteristics. In ESCs, Oct1 localized with the pluripotency factor Oct4 at mesoderm-associated genes and remained bound to those loci during differentiation after the dissociation of Oct4. Binding events for Oct1 overlapped with those for the histone lysine demethylase Utx, and an interaction between Oct1 and Utx suggested that these two proteins cooperate to activate gene expression. The specificity of the ubiquitous Oct1 for the induction of mesodermal genes could be partially explained by the frequent coexistence of Smad and Oct binding sites at mesoderm-specific genes and the cooperative stimulation of mesodermal gene transcription by Oct1 and Smad3. Together, these results identify Oct1 as a key mediator of mesoderm lineage-specific gene induction.

Indexed as

Embryonic Stem CellsTranscription FactorsAnimalsBinding SitesCell DifferentiationCell LineageMesodermMiceTranscription Factors

Identifiers

PMID37071732
PMCPMC10360295
OpenAlexW4366252105

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.